Fig. 4
From: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Overall survival in patients with normal and elevated CEA levels.
Fig. 4 | Scientific Reports
From: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Overall survival in patients with normal and elevated CEA levels.
